Profil

Lee Sing-E

See author's contact details
Main Referenced Co-authors
Abelson, M. (1)
Aboufakher, R. (1)
Abrahamsen, T. E. (1)
Accini Mendoza, J. L. (1)
Acheatel, R. (1)
Ackermann, D. (1)
Main Referenced Keywords
Aged (1); Antibodies, Monoclonal (1); Anticholesteremic Agents (1); Article (1); Atherosclerosis (1);
Main Referenced Disciplines
Cardiovascular & respiratory systems (1)
Endocrinology, metabolism & nutrition (1)
Pharmacy, pharmacology & toxicology (1)

Publications (total 1)

The most downloaded
8 downloads
Sabatine, M. S., Giugliano, R. P., Keech, A. C., Honarpour, N., Wiviott, S. D., Murphy, S. A., Kuder, J. F., Wang, H., Liu, T., Wasserman, S. M., Sever, P. S., Pedersen, T. R., Fish, M. P., Abrahamsen, T. E., Im, K., Kanevsky, E., Bonaca, M. P., Lira Pineda, A., Hanlon, K., ... Chapman, K. (2017). Evolocumab and clinical outcomes in patients with cardiovascular disease. New England Journal of Medicine, 376 (18), 1713-1722. doi:10.1056/NEJMoa1615664 https://hdl.handle.net/2268/235343

The most cited

3985 citations (Scopus®)

Sabatine, M. S., Giugliano, R. P., Keech, A. C., Honarpour, N., Wiviott, S. D., Murphy, S. A., Kuder, J. F., Wang, H., Liu, T., Wasserman, S. M., Sever, P. S., Pedersen, T. R., Fish, M. P., Abrahamsen, T. E., Im, K., Kanevsky, E., Bonaca, M. P., Lira Pineda, A., Hanlon, K., ... Chapman, K. (2017). Evolocumab and clinical outcomes in patients with cardiovascular disease. New England Journal of Medicine, 376 (18), 1713-1722. doi:10.1056/NEJMoa1615664 https://hdl.handle.net/2268/235343

Sabatine, M. S., Giugliano, R. P., Keech, A. C., Honarpour, N., Wiviott, S. D., Murphy, S. A., Kuder, J. F., Wang, H., Liu, T., Wasserman, S. M., Sever, P. S., Pedersen, T. R., Fish, M. P., Abrahamsen, T. E., Im, K., Kanevsky, E., Bonaca, M. P., Lira Pineda, A., Hanlon, K., ... Chapman, K. (2017). Evolocumab and clinical outcomes in patients with cardiovascular disease. New England Journal of Medicine, 376 (18), 1713-1722. doi:10.1056/NEJMoa1615664
Peer Reviewed verified by ORBi

Contact ORBi